Clinical management of venetoclax in multiple myeloma
Prognostic markers for CLL - how do they help determine who gets which treatment?
The importance of venetoclax in treating CLL
The impact of genetic testing on treatment selection in CLL
The role of Richter’s syndrome in determining the prognosis of CLL patients
Matthew Steven Davids